Your browser doesn't support javascript.
loading
Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide.
Jamieson, David; Sunter, Nicola; Muro, Sara; Pouché, Lucie; Cresti, Nicola; Lee, Johanne; Sludden, Julieann; Griffin, Melanie J; Allan, James M; Verrill, Mark W; Boddy, Alan V.
Afiliación
  • Jamieson D; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Sunter N; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Muro S; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Pouché L; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Cresti N; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; Northern Centre for Cancer Care, Newcastle Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.
  • Lee J; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Sludden J; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Griffin MJ; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Allan JM; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Verrill MW; Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; Northern Centre for Cancer Care, Newcastle Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.
  • Boddy AV; Faculty of Pharmacy, Pharmacy and Bank Building (A15), University of Sydney, Science Road, NSW 2006, Australia. Electronic address: alan.boddy@sydney.edu.au.
Eur J Cancer ; 71: 15-24, 2017 01.
Article en En | MEDLINE | ID: mdl-27940354
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Doxorrubicina / Quimioterapia Adyuvante / Receptor fas / Polimorfismo de Nucleótido Simple / Ciclofosfamida / Lectina de Unión a Manosa / Infecciones Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Doxorrubicina / Quimioterapia Adyuvante / Receptor fas / Polimorfismo de Nucleótido Simple / Ciclofosfamida / Lectina de Unión a Manosa / Infecciones Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido